Powles, T., Koshkin, V. S., Rosenberg, J. E., Matsubara, N., Brown, J. R., Drakaki, A., Campbell, M. T., Oliveira, N., Burgess, E., Iyer, G., Peer, A., Chan, J., Cutuli, H., Eigl, B. J., Jones, R., Aragon-Ching, J. B., Schuman, J., Yang, M., Sokolowski, K. M., Galsky, M. D. (2026). RC48G001: A phase 2 study of disitamab vedotin in HER2-expressing previously treated advanced UC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.lba631